Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-93
Closed -$9.79K 245
2025
Q4
$9.79K Buy
+93
New +$8.73K ﹤0.01% 150
2025
Q2
Sell
-141
Closed -$12.7K 206
2025
Q1
$12.7K Sell
141
-651
-82% -$60.8K ﹤0.01% 150
2024
Q4
$78.8K Buy
+792
New +$81.7K 0.04% 82
2024
Q3
Sell
-185
Closed -$22.9K 277
2024
Q2
$22.9K Buy
+185
New +$23.8K 0.01% 88

Other funds holding MRK

Fairway Wealth's MRK Position: Q1 2026 in Review

Fairway Wealth sold out of Merck (MRK) in Q1 2026, closing a stake of 93 shares — an estimated $9.79K sold.

Fairway Wealth first reported a position in MRK in Q2 2024 and held it in 4 quarters. The position peaked at $78.8K in Q4 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Fairway Wealth reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Fairway Wealth sold 93 Merck shares in Q1 2026, an estimated $9.79K.
  • Fairway Wealth first reported a position in Merck in Q2 2024 and held it in 4 quarters.
  • Fairway Wealth's Merck position peaked at $78.8K in Q4 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Fairway Wealth's 13F filing for Q1 2026, filed 23 Apr 2026.